Loading

IMS to Big Pharma: Get moving!

Is it possible that Big isn’t moving fast enough into emerging markets? That’s the implication of a new report from IMS . According to the market research firm, 17 “pharmerging” markets will account for almost half of

Add this post to your favorites social bookmark

Bookmark and Share